blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0277151

EP0277151 - NOVEL MEDICINAL USE OF NUCLEOSIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.08.1992
Database last updated on 18.10.2024
Most recent event   Tooltip20.08.1992No opposition filed within time limitpublished on 07.10.1992 [1992/41]
Applicant(s)For all designated states
Medivir Aktiebolag
Lunastigen 7
S-141 44 Huddinge / SE
[1989/24]
Former [1988/32]For all designated states
ASTRA LAKEMEDEL AKTIEBOLAG
S-151 85 Södertälje / SE
Inventor(s)01 / ERIKSSON, Bertil, Frank, Harald
Lindhovsvägen 35
S-147 00 Tumba / SE
02 / JOHANSSON, Karl, Nils, Gunnar
Bäverstigen 19
S-150 23 Enhörna / SE
03 / STENING, Göran, Bertil
Varbovägen 10
S-151 50 Södertälje / SE
04 / ÖBERG, Bo, Fredrik
Askvägen 27
S-752 52 Uppsala / SE
[1988/32]
Representative(s)Larfeldt, Helene, et al
Bergensträhle & Lindvall AB
P.O. Box 17704
118 93 Stockholm / SE
[N/P]
Former [1989/24]Larfeldt, Helene, et al
Bergensträhle & Lindvall AB Sankt Paulsgatan 1
S-116 47 Stockholm / SE
Former [1988/32]Hjertman, Ivan T.
AB ASTRA Patent and Trade Mark Department
S-151 85 Södertälje / SE
Application number, filing date87904641.502.07.1987
[1988/32]
WO1987SE00316
Priority number, dateSE1986000298104.07.1986         Original published format: SE 8602981
[1988/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO8800050
Date:14.01.1988
Language:EN
[1988/02]
Type: A1 Application with search report 
No.:EP0277151
Date:10.08.1988
Language:EN
The application published by WIPO in one of the EPO official languages on 14.01.1988 takes the place of the publication of the European patent application.
[1988/32]
Type: B1 Patent specification 
No.:EP0277151
Date:16.10.1991
Language:EN
[1991/42]
Type: B1 RE Reissue of patent specification
No.:EP0277151
Date:21.07.1992
[1992/37]
Search report(s)International search report - published on:SE14.01.1988
ClassificationIPC:A61K31/70, C07H19/04, C07H19/06, C07H19/16
[1988/32]
CPC:
A61K31/70 (EP,US); A61P31/12 (EP); A61P43/00 (EP);
C07H19/06 (EP,US); C07H19/16 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1988/32]
TitleGerman:MEDIZINISCHE VERWENDUNG VON NUKLEOSIDEN[1988/32]
English:NOVEL MEDICINAL USE OF NUCLEOSIDES[1988/32]
French:NOUVELLE APPLICATION MEDICINALE DE NUCLEOSIDES[1988/32]
Entry into regional phase10.02.1988National basic fee paid 
10.02.1988Designation fee(s) paid 
10.02.1988Examination fee paid 
Examination procedure10.02.1988Examination requested  [1988/32]
21.11.1989Despatch of a communication from the examining division (Time limit: M04)
16.03.1990Reply to a communication from the examining division
30.07.1990Despatch of communication of intention to grant (Approval: No)
09.11.1990Despatch of communication of intention to grant (Approval: later approval)
10.12.1990Communication of intention to grant the patent
04.03.1991Fee for grant paid
04.03.1991Fee for publishing/printing paid
Opposition(s)17.07.1992No opposition filed within time limit [1992/41]
Fees paidRenewal fee
02.09.1989Renewal fee patent year 03
31.07.1990Renewal fee patent year 04
29.07.1991Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
01.08.198903   M06   Fee paid on   02.09.1989
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.10.1991
[1992/29]
Cited inInternational search[X]DD158903  (KOWOLLIK GOTTHARD, et al);
 [X]DD209197  (AKAD WISSENSCHAFTEN DDR [DD]);
 [AP]EP0206497  (WELLCOME FOUND [GB])
 [X]  - Journal fur Praktische Chemie, Volume 315, No. 5, issued 1973 (Leipzig), G. KOWOLLIK et al, "Ein Neuer Zugang zu 1- (2,3-Didesoxy-3-fluor-beta-D-Ribofuranosyl)- Pyrimidinen", see pages 895-900, especially p. 895, second Paragraph.
 [X]  - CHEMICAL ABSTRACTS, Vol. 84 (1976), Abstract No. 25824 u, Vopr. Virusol. 1975, (5), 625-6 (Russ).
 [A]  - CHEMICAL ABSTRACTS, Vol. 102 (1985), Abstract No. 39565 n, J. Cell. Physiol. 1984, 121 (2), 402-8 (Eng), see especially the last three lines of the Abstract.
 [X]  - Progress in Antimicrobial and Anticancer Chemotherapy: Proceedings of the 6th International Congress of Chemotherapy, Volume II, published 1970, by Iniversity Park Press (Baltimore), see pages 394-397, especially p. 397, lines 11-12 after the table.
Examination   - Chemical Abstracts, vol. 102 (1985), abstract no. 39565n, J. Cell. Physiol. 1984, 212 (2), 402-8 (Eng), see esp. the last three lines of the abstract
    - Acta biol. med. germ., vol. 23, (1969), page 750-766. P. Langen et al
    - R. Koshida et al., Antimicrobial Agents & Chemotherapy, vol. 33, no. 5 (1989), page 778-780
    - Herdewijn et al., Journal of Medical Chemistry, vol. 30, (1987), pages 1270-1278
    - Bazin et al., Biochemical Pharmacology, vol. 38 (1989), pages 109-119
    - Pilarica et al., Journal gen. Virol., vol. 2, (1968), pages 357-364
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.